Data analytics, machine learning, and investment compliance
Financial institutions that employ investment advisers to manage client portfolios and regulatory authorities that monitor those advisers have not fully...
Dr. Rahul Surana is a vice president in the Finance Practice of CRA. Dr. Surana is an expert in disputes related to securities transactions and capital markets and has testified in US and International courts.
He has over 15 years of experience in class certification matters and has consulted on economic analyses, damage exposures, expected settlements, and on loss causation arguments. Dr. Surana’s work has been used in both initial settlement discussions, and for fairness of final class action settlements. Dr. Surana also published an article analyzing the economic impact of class action settlements.
Dr. Surana is a FINRA arbitrator and sits on a panel of judges to hear disputes between investors and securities firms. FINRA is the largest independent regulator of securities firms in the United States. As an arbitrator, he hears all sides of the issues as presented by parties, studies evidence, and then provides his decision on how the matter should be resolved.
Dr. Surana has published in peer-reviewed journals and has presented in leading academic conferences. He is a CFA (Chartered Financial Analyst) charter holder, and holds CAIA (Chartered Alternative Investment Analyst), FRM (Financial Risk Manager) an ERP (Energy Risk Professional) certifications. Dr. Surana holds a PhD in engineering from Penn State University and an MBA from the University of California at Berkeley.
Dr. Surana’s CFA and CAIA certifications have provided him with tools and know how to value security investments, business, and intangibles such as intellectual property. He has testified in US on security investment related matter wherein the allegations involved suitability of investment of settlement proceeds. Dr. Surana has provided an expert report on valuation of a private semiconductor company in Canada and has testified in international arbitrations on value of technology in London and on economic damages related to pricing of specialty chemicals in Taiwan.